NCT03659448: An ongoing trial by Surgimab
This trial is ongoing. It must report results 2 weeks, 1 day ago.
Full data
| Full entry on ClinicalTrials.gov | NCT03659448 |
|---|---|
| Title | Multicenter, Open-label, Randomized, Controlled, Parallel Arms Clinical Study on Performance of SGM-101, a Fluorochrome-labeled Anti-CEA Monoclonal Antibody, for Delineation of Primary/Recurrent Tumor and Metastases in Patients Undergoing Surgery for Colorectal Cancer |
| Results Status | Ongoing |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | June 17, 2019 |
| Completion date | Nov. 30, 2024 |
| Required reporting date | Nov. 30, 2025, midnight |
| Actual reporting date | None |
| Date last checked at ClinicalTrials.gov | Dec. 12, 2025 |
| Days late | None |